Conversations on the Business of Health Care
Issues in Global Health:
Advancing Efficiency and Quality Through Regulatory Science
Presented By:
The Johns Hopkins Carey Business School
In partnership with
The Food and Drug Law Institute
Highlights from the December 2, 2011 Event:
A candid exploration of the business, economic, political, scientific, public health, and implementation issues in pharmaceutical and medical device company inspections and quality compliance oversight by regulators all over the world.
Professor Dipankar Chakravarti of the Carey Business School convened and moderated the day’s events.
Panel Discussion 1: Strengthening Compliance & Enforcement: The Challenges of Globalization
Moderator: Robert Wanerman, Senior Counsel, Epstein Becker Green
Panelists:
Dr. Vicki Seyfert-Margolis, Senior Advisor, Science Innovation and Policy, Office off Innovation, US FDA
Hilde Boone, European Medicines Agency, Liaison Official at US FDA
Robert Stewart, Executive Vice President, Global Operations, Watson Pharmaceuticals
Panel Discussion 2: Strengthening Compliance & Enforcement: Global Supply Chain Realities
Moderator: Susan Winckler, Exec. Director FDLI
Panelists:
Ron Ginor, Chief Executive Officer, Becker & Associates
Lillian Gill, Deputy Director, Cosmetic Ingredient Review
Tom Colonna, Associate Director, Bioscience Regulatory Affairs Program, Johns Hopkins University
Funding provided by Johnson & Johnson